Pancreaticobiliary Diseases Program
Following Houston Methodist’s tradition of leading medicine, the Pancreaticobiliary Diseases Program in the Lynda K. and David M. Underwood Center for Digestive Disorders provides innovative, extensive and exceptional surgical and nonsurgical care for patients with diseases of the pancreas, gallbladder and biliary system. Our team of nationally and internationally recognized specialists, including gastroenterologists, interventional endoscopists, radiologists, surgeons, medical oncologists, radiation oncologists and pathologists, is committed to delivering optimal individualized treatments ensuring superior outcomes — from diagnosis to treatment to rehabilitation.
Why Houston Methodist?
Houston Methodist Hospital is ranked No. 10 by U.S. News & World Report for digestive diseases and the highest nationally ranked hospital in Texas and the Gulf Coast for digestive diseases. U.S. News & World Report has also named Houston Methodist Hospital the No. 1 hospital in Texas every year since the award began and one of the nation’s best as a nationally ranked Honor Roll hospital. Learn more.
We have access to state-of-the-art technology, including:
- Diagnostic and therapeutic pancreaticobiliary endoscopy
- Diagnostic and therapeutic endoscopic ultrasound
- Multi-slice CT scanning
- Magnetic resonance imaging (MRI)
- Positron emission tomography (PET)
- Laparoscopic surgical techniques
- Multiple radiation and personalized systemic targeted therapy options for cancer treatment
Our experts continuously evaluate patients through weekly GI tumor boards and conferences to ensure implementation of the most appropriate and effective treatment plans. Moreover, Houston Methodist’s clinicians and scientists work to advance discoveries of innovative and personalized treatments.
We also are dedicated to partnering with referring physicians to best preserve the primary patient-physician relationship and ensure seamless return-to-care following successful completion of treatment.
The Pancreaticobiliary Diseases Program offers patients:
- Quick evaluation and access to skilled patient navigators
- On-site treatments
- Opportunities to enroll in the latest research studies
- Patient education
- Recovery and rehabilitation assistance
- Pancreatic cancer, bile duct cancer and other tumors (adenocarcinoma, neuroendocrine neoplasm, cholangiocarcinoma, intraductal papillary mucinous neoplasms)
- Cystic lesions of the pancreas
- Acute and chronic pancreatitis
- Pancreatic pseudocysts
- Post-cholecystectomy syndrome
- Primary sclerosing cholangitis
- Benign bile duct strictures